DRLAX
Price
$8.26
Change
+$0.12 (+1.47%)
Updated
Apr 17 closing price
Net Assets
284.82M
GRSRX
Price
$51.64
Change
+$0.79 (+1.55%)
Updated
Apr 17 closing price
Net Assets
1.91B
Ad is loading...

DRLAX vs GRSRX

Header iconDRLAX vs GRSRX Comparison
Open Charts DRLAX vs GRSRXBanner chart's image
BNY Mellon Developed Markets RE Scs - A
Price$8.26
Change+$0.12 (+1.47%)
VolumeN/A
Net Assets284.82M
Cohen & Steers Global Realty R
Price$51.64
Change+$0.79 (+1.55%)
VolumeN/A
Net Assets1.91B
DRLAX vs GRSRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DRLAX vs. GRSRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRLAX is a StrongBuy and GRSRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GRSRX has more cash in the bank: 1.91B vs. DRLAX (285M). DRLAX pays higher dividends than GRSRX: DRLAX (2.42) vs GRSRX (2.29). DRLAX was incepted earlier than GRSRX: DRLAX (18 years) vs GRSRX (11 years). DRLAX (1.77) is less costly to investors than GRSRX (1.34). GRSRX is a more actively managed with annual turnover of: 52.00 vs. DRLAX (47.81). GRSRX has a lower initial minimum investment than DRLAX: GRSRX (0) vs DRLAX (1000). DRLAX annual gain was more profitable for investors over the last year : 12.07 vs. GRSRX (8.55). GRSRX return over 5 years is better than : 27.79 vs. DRLAX (20.98).
DRLAXGRSRXDRLAX / GRSRX
Total Expense Ratio1.301.3497%
Annual Report Gross Expense Ratio1.771.34132%
Fund Existence18 years11 years-
Gain YTD-1.094-0.606180%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M1.91B15%
Annual Yield % from dividends2.422.29106%
Returns for 1 year12.078.55141%
Returns for 3 years-15.59-13.85113%
Returns for 5 years20.9827.7976%
Returns for 10 years3.1626.1112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTCAX16.09N/A
N/A
BNY Mellon Sust US Equity A
GSCGX28.83N/A
N/A
Goldman Sachs Large Cap Core A
PXGOX15.46N/A
N/A
Impax Global Opportunities Institutional
EEMDX7.67N/A
N/A
MFS Emerging Markets Equity Research R1
JACNX23.82-0.10
-0.42%
Janus Henderson Contrarian D